The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,499
Sort by:
Investigation Report on China's Iohexol Market 2021-2025
US$ 2,600.00
Iohexol is a non-ionic X-ray contrast agent. Iohexol injection is suitable for intravascular and intracavitary injections in adults and children. In clinical angiography (cerebrovascular angiography,...
July 2021
50 pages
Investigation Report on China's Linezolid Market 2021-2025
US$ 2,600.00
Linezolid is an oxazolidinone antibiotic, mainly used to treat infections caused by gram-positive (G+) cocci, including suspected or confirmed hospital-acquired pneumonia (HAP) caused by methicillin-r...
July 2021
50 pages
Investigation Report on China's Metformin Market 2021-2025
US$ 2,600.00
Metformin is the first-line drug for the treatment of type 2 diabetes, especially in people who are overweight. Metformin was originally developed by Merck Sharp & Dohme (trade name: GLUCOPHAGE ). GLU...
July 2021
50 pages
Investigation Report on China's Nifedipine Market 2021-2025
US$ 2,600.00
Nifedipine is a dihydropyridine calcium channel blocker, which is mainly used to bind to L-type calcium channels. Nifedipine is mainly used to treat chronic stable angina pectoris, vasospasm angina pe...
July 2021
50 pages
Investigation Report on China's Octreotide Market 2021-2025
US$ 2,600.00
Octreotide is a derivative of artificially modified natural somatostatin, which is an octapeptide. Its physiological effects include inhibiting growth hormone function, inhibiting the secretion of gas...
July 2021
50 pages
Research Report on China's Mecobalamin Market, 2021-2025
US$ 2,600.00
Mecobalamin is an endogenous coenzyme B12, which has a good effect on neuronal conduction compared with other types of vitamin B12, and can promote nucleic acid-protein-lipid metabolism through methyl...
July 2021
50 pages
Lumakras Drug Clinical Insight & Sales Forecast 2026
US$ 2,000.00
Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. “Lumakras Drug Clinical Insight & Sales Forecast 2026” Report Highlights:NSCLC Targeting...
July 2021
60 pages
Vitamin China E-News
US$ 2,916.00
... on the entire vitamin industry chain, from raw materials to end consumption. It includes breaking news from China and abroad, the ... Its subsidiary Xinnuowei Pharmaceutical has eventually been approved to be listed. Vitamins China E-News is a monthly published newsletter, which can be downloaded in PDF ...
June 2021
43 pages
5-Hydroxytryptamine Receptor 7 - Drugs In Development, 2021
US$ 3,500.00
5-Hydroxytryptamine Receptor 7 - Drugs In Development, 2021 SUMMARY According to the recently published report '5-Hydroxytryptamine Receptor 7 - Drugs In Development, 2021'; 5-Hydroxytryptamine Recept...
June 2021
85 pages
Apoptosis Regulator BAX - Drugs In Development, 2021
US$ 3,500.00
Apoptosis Regulator BAX - Drugs In Development, 2021 SUMMARY Apoptosis Regulator BAX (Bcl 2 Like Protein 4 or BCL2L4 or BAX) - Apoptosis regulator BAX or bcl-2-like protein 4 is a protein is encoded b...
June 2021
46 pages
Arrhythmias (Cardiovascular) - Drugs In Development, 2021
US$ 2,000.00
Arrhythmias (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Arrhythmias (Cardiovascular) - Drugs In Developmen...
June 2021
92 pages
Aryl Hydrocarbon Receptor - Drugs In Development, 2021
US$ 3,500.00
Aryl Hydrocarbon Receptor - Drugs In Development, 2021 SUMMARY According to the recently published report 'Aryl Hydrocarbon Receptor - Drugs In Development, 2021'; Aryl Hydrocarbon Receptor (Class E B...
June 2021
139 pages
